Entasis Therapeutics Holdings Insider Trades

ETTX

Track insider trading activity from Entasis Therapeutics Holdings executives and directors. See which insiders are buying and selling ETTX stock.

Trades Last 12 Months

ETTX Price

All Insider Trades for Entasis Therapeutics Holdings

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Altarac David Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$312k 142,307 shares
$2.19
$2.19
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$60.5k 27,500 shares
$2.20
$2.19
Mayer Howard Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$60.5k 27,500 shares
$2.20
$2.19
Meek David D. Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$62k 28,307 shares
$2.19
$2.19
Perros Manoussos President And CEO
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.05M 478,500 shares
$2.19
$2.19
Tommasi Ruben Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Jul 11, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$329k 150,000 shares
$2.19
$2.19
Holding Value $64.1M 29,270,476 shares
Last Trade
Jul 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.7M 7,598,814 shares
$2.20
$2.19
Gutch Michael See Remarks
Holding Value $367k 167,572 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 125,000 shares
$1.92
$2.19
Behanna Heather Director
Holding Value $108k 49,500 shares
Last Trade
Jan 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.8k 27,500 shares
$1.92
$2.19
Ronsheim Matthew Chief Of Pharmaceutical Sciences And Manufacturing
Holding Value $0 0 shares
Last Trade
Jul 16, 2021 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$97.6k 40,000 shares
$2.44
$2.19
Innoviva, Inc. 10% owner
Holding Value $21.9M 10,000,000 shares
Last Trade
Jun 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$16.8M 6,268,975 shares
$2.68
$2.19
Hastings David C Director
Holding Value $48.2k 22,000 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 22,000 shares
$2.16
$2.19
Mueller John Patrick Chief Development Officer
Holding Value $54.8k 25,000 shares
Last Trade
Jan 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66k 25,000 shares
$2.64
$2.19
Keiley Elizabeth M General Counsel
Holding Value $54.8k 25,000 shares
Last Trade
Jan 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66k 25,000 shares
$2.64
$2.19
Kimble Eric Wilson Chief Commercial Officer
Holding Value $110k 50,000 shares
Last Trade
Jan 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 50,000 shares
$4.94
$2.19
Holding Value $2.85M 1,299,953 shares
Last Trade
Jan 09, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$250k 50,000 shares
$5.00
$2.19
Norden Gregory Director
Holding Value $16.4k 7,500 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.9k 7,500 shares
$6.12
$2.19
Holding Value $16.4k 7,500 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.9k 7,500 shares
$6.12
$2.19
Preston Heather Director
Holding Value $16.4k 7,500 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.9k 7,500 shares
$6.12
$2.19
Topper James N 10% owner
Holding Value $32.9k 15,000 shares
Last Trade
Jan 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.9k 15,000 shares
$5.66
$2.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up